Published in Am J Hematol on February 01, 2005
Factor VIII products and inhibitor development in severe hemophilia A. N Engl J Med (2013) 2.99
Synthesis, antiproliferative and apoptotic activities of N-(6(4)-indazolyl)-benzenesulfonamide derivatives as potential anticancer agents. Eur J Med Chem (2012) 2.56
A "twist box" code of p53 inactivation: twist box: p53 interaction promotes p53 degradation. Cancer Cell (2012) 1.81
Molecular analysis and characterization of nine novel CTSK mutations in twelve patients affected by pycnodysostosis. Mutation in brief #961. Online. Hum Mutat (2007) 1.47
The implementation of SOMO (SOlution MOdeller) in the UltraScan analytical ultracentrifugation data analysis suite: enhanced capabilities allow the reliable hydrodynamic modeling of virtually any kind of biomacromolecule. Eur Biophys J (2009) 1.35
Bisphenol A induces gene expression changes and proliferative effects through GPER in breast cancer cells and cancer-associated fibroblasts. Environ Health Perspect (2012) 1.27
Integrin conformational regulation: uncoupling extension/tail separation from changes in the head region by a multiresolution approach. Structure (2008) 1.16
Management of chronic childhood immune thrombocytopenic purpura: AIEOP consensus guidelines. Acta Haematol (2009) 1.16
Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells. Mol Cell Endocrinol (2010) 1.14
Synthesis and antitumor activity of some substituted indazole derivatives. Arch Pharm (Weinheim) (2014) 1.07
IDUA mutational profiling of a cohort of 102 European patients with mucopolysaccharidosis type I: identification and characterization of 35 novel α-L-iduronidase (IDUA) alleles. Hum Mutat (2011) 1.07
MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells. Breast Cancer Res (2012) 1.00
Structure, conformational stability, and enzymatic properties of acylphosphatase from the hyperthermophile Sulfolobus solfataricus. Proteins (2006) 0.99
Monitoring the process of HypF fibrillization and liposome permeabilization by protofibrils. J Mol Biol (2004) 0.99
t(9;11)(p22;p15) with NUP98-LEDGF fusion gene in pediatric acute myeloid leukemia. Leuk Res (2004) 0.96
Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia. Am J Hematol (2010) 0.95
Conditions associated with infections of indwelling central venous catheters in cancer patients: a summary. Br J Haematol (2003) 0.95
Three-dimensional structural characterization of a novel Drosophila melanogaster acylphosphatase. Acta Crystallogr D Biol Crystallogr (2004) 0.94
Molecular analysis of NPC1 and NPC2 gene in 34 Niemann-Pick C Italian patients: identification and structural modeling of novel mutations. Neurogenetics (2009) 0.92
Synthesis and biological evaluation of novel pyrazole derivatives with anticancer activity. Eur J Med Chem (2011) 0.91
First pilot newborn screening for four lysosomal storage diseases in an Italian region: identification and analysis of a putative causative mutation in the GBA gene. Clin Chim Acta (2012) 0.89
MicroRNA-125b-1 and BLID upregulation resulting from a novel IGH translocation in childhood B-Cell precursor acute lymphoblastic leukemia. Genes Chromosomes Cancer (2010) 0.89
Identification and molecular characterization of six novel mutations in the UDP-N-acetylglucosamine-1-phosphotransferase gamma subunit (GNPTG) gene in patients with mucolipidosis III gamma. Hum Mutat (2009) 0.88
Etanercept as a salvage treatment for refractory aplastic anemia. Pediatr Blood Cancer (2009) 0.87
Familial nonrandom inactivation linked to the X inactivation centre in heterozygotes manifesting haemophilia A. Eur J Hum Genet (2005) 0.87
Incidence of catheter-related infections within 30 days from insertion of Hickman-Broviac catheters. Pediatr Blood Cancer (2007) 0.86
Inversion (11)(p15q22) with NUP98-DDX10 fusion gene in pediatric acute myeloid leukemia. Cancer Genet Cytogenet (2006) 0.85
Diagnostic potential of hepcidin testing in pediatrics. Eur J Haematol (2013) 0.85
Emerging issues on comprehensive hemophilia care: preventing, identifying, and monitoring age-related comorbidities. Semin Thromb Hemost (2013) 0.84
Consumption of clotting factors in severe haemophilia patients undergoing prophylaxis and on-demand treatment in Italy. Transfus Med (2011) 0.84
Structure-activity relationships of resveratrol and derivatives in breast cancer cells. Mol Nutr Food Res (2009) 0.84
Severe congenital neutropenia: a negative synergistic effect of multiple mutations of ELANE (ELA2) gene. Br J Haematol (2009) 0.84
Pegfilgrastim in children with severe congenital neutropenia. Pediatr Blood Cancer (2010) 0.84
Analysis of 18 novel mutations in the factor VIII gene. Br J Haematol (2003) 0.84
Cerebrovascular disease and varicella in children. Brain Dev (2006) 0.82
Etanercept treatment in Fanconi anaemia; combined US and Italian experience. Br J Haematol (2012) 0.82
Oleuropein and hydroxytyrosol activate GPER/ GPR30-dependent pathways leading to apoptosis of ER-negative SKBR3 breast cancer cells. Mol Nutr Food Res (2013) 0.82
Development and definition of a simplified scanning procedure and scoring method for Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US). Thromb Haemost (2013) 0.81
Segregation analysis in a family at risk for the Maroteaux-Lamy syndrome conclusively reveals c.1151G>A (p.S384N) as to be a polymorphism. Eur J Hum Genet (2009) 0.81
HCMOGT-1 is a novel fusion partner to PDGFRB in juvenile myelomonocytic leukemia with t(5;17)(q33;p11.2). Cancer Res (2004) 0.81
Identification of two benzopyrroloxazines acting as selective GPER antagonists in breast cancer cells and cancer-associated fibroblasts. Future Med Chem (2015) 0.81
Molecular analysis of ARSA and PSAP genes in twenty-one Italian patients with metachromatic leukodystrophy: identification and functional characterization of 11 novel ARSA alleles. Hum Mutat (2008) 0.81
Possible role of toll-like receptor 9 polymorphism in chemotherapy-related invasive mold infections in children with hematological malignancies. Pediatr Blood Cancer (2008) 0.80
Poikiloderma with neutropenia: a case report and review of the literature. J Pediatr Hematol Oncol (2014) 0.80
Benefits of prophylaxis versus on-demand treatment in adolescents and adults with severe haemophilia A: the POTTER study. Thromb Haemost (2015) 0.80
Prevention of venous thromboembolism in patients with cancer: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)(1). Thromb Res (2011) 0.80
(6-bromo-1,4-dimethyl-9H-carbazol-3-yl-methylene)-hydrazine (carbhydraz) acts as a GPER agonist in breast cancer cells. Curr Top Med Chem (2015) 0.79
Expanded spectrum of Pelizaeus-Merzbacher-like disease: literature revision and description of a novel GJC2 mutation in an unusually severe form. Eur J Hum Genet (2012) 0.79
Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey. Haemophilia (2014) 0.79
Rituximab-based immunosuppression for autoimmune haemolytic anaemia in infants. Br J Haematol (2009) 0.78
Human sirtuins: an overview of an emerging drug target in age-related diseases and cancer. Curr Drug Targets (2013) 0.78
Cyto-morphologic evaluation of bone marrow in infants with disseminated neuroblastoma. J Pediatr Hematol Oncol (2012) 0.78
Health emigration: a challenge in paediatric oncology. J Child Health Care (2008) 0.78
Sequence and copy number analyses of HEXB gene in patients affected by Sandhoff disease: functional characterization of 9 novel sequence variants. PLoS One (2012) 0.78
Ciprofloxacin prophylaxis in children with acute leukemia in an era of increasing antibiotic resistance. Pediatr Infect Dis J (2013) 0.78
Drug delivery with a calixpyrrole--trans-Pt(II) complex. J Am Chem Soc (2013) 0.78
A single institution observational study of early mechanical complications in central venous catheters (valved and open-ended) in children with cancer. Pediatr Surg Int (2004) 0.78
A practical approach to diagnosis and treatment of symptomatic thromboembolic events in children with acute lymphoblastic leukemia: recommendations of the "Coagulation Defects" AIEOP Working Group. Recent Pat Cardiovasc Drug Discov (2007) 0.77
N-acylated and N,N'-diacylated imidazolidine-2-thione derivatives and N,N'-diacylated tetrahydropyrimidine-2(1H)-thione analogues: synthesis and antiproliferative activity. Eur J Med Chem (2008) 0.77
Issues in pediatric haemophilia care. Ital J Pediatr (2013) 0.77
Frequency of factor VIII intron 1 inversion in a cohort of severe hemophilia A Italian patients. Haematologica (2003) 0.77
Preliminary characterization of two different crystal forms of acylphosphatase from the hyperthermophile archaeon Sulfolobus solfataricus. Acta Crystallogr Sect F Struct Biol Cryst Commun (2004) 0.77
Duplication of exon 13 causes one third of the cases of mild hemophilia A in northern Italy. Haematologica (2004) 0.77
Uncommon EGFR Exon 19 Mutations Confer Gefitinib Resistance in Advanced Lung Adenocarcinoma. J Thorac Oncol (2015) 0.75
Inhibition of MDR1 activity and induction of apoptosis by analogues of nifedipine and diltiazem: an in vitro analysis. Invest New Drugs (2009) 0.75
Expression, purification and preliminary crystallographic studies on the catalytic region of the nonreceptor tyrosine kinase Fes. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 0.75
Mutation analysis impact on the genetic counseling of sporadic hemophilia B families. Am J Med Genet A (2003) 0.75
Exon skipping partially restores factor VIII coagulant activity in patients with mild hemophilia A with exon 13 duplication. Haematologica (2005) 0.75
von Willebrand factor multimer composition is modified following oral methionine load in women with thrombosis, but not in healthy women. Blood Coagul Fibrinolysis (2005) 0.75
Unusual presentation of haemophilia in two paediatric patients. Blood Coagul Fibrinolysis (2013) 0.75
Genetic analysis in FXI deficient patients from northwestern Italy: three novel and one recurrent mutation. Eur J Haematol (2013) 0.75
Ectopic mRNA analysis and molecular modelling substantiate severe haemophilia in a patient with a FVIII gene splice mutation. Thromb Haemost (2005) 0.75
Sirolimus for the treatment of multi-resistant autoimmune haemolytic anaemia in children. Br J Haematol (2014) 0.75